Medifast Inc
Last updated September 27, 2026
Organization details
- Legal name
- Medifast Inc
- Former names
- Healthrite Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 2090 — Miscellaneous Food Preparations & Kindred Products
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Baltimore
- Headquarters state / province
- Maryland
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MED
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000910329
- EIN
- 13-3714405
Board of directors
-
Andrea B. Thomas · DirectorSince 2023
-
Constance J. Hallquist · DirectorSince 2023
-
Daniel R. Chard · Director · Chairman & CEOSince 2023
-
Elizabeth A. Geary · DirectorSince 2023
-
Jeffrey J. Brown · DirectorSince 2023
-
Jeffrey Matthew Rose · DirectorSince 2026
-
Michael A. Hoer · DirectorSince 2023
-
Ming Xian · DirectorSince 2023
-
Parsa Kiai · DirectorSince 2026
-
Scott Schlackman · DirectorSince 2023
Chief executives
Daniel R. Chard
· Chairman & CEO
Dates unknown
Director election results
Annual meeting of May 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
82.9%
-
91.9%
-
92.3%
-
93.0%
-
94.4%
-
94.4%
-
94.9%
Board connections
1 of this board's directors also sit on 1 other board.
- via Jeffrey J. Brown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,665,477
- 11 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 26, 2026 | Parsa Kiai Director | Open-market purchase | +41,975 | $12.26 | $514,748 |
| Aug 26, 2026 | Parsa Kiai Director | Open-market purchase | +1,175 | $12.26 | $14,409 |
| Aug 24, 2026 | Parsa Kiai Director | Open-market purchase | +4,211 | $12.00 | $50,530 |
| Aug 24, 2026 | Parsa Kiai Director | Open-market purchase | +118 | $12.00 | $1,416 |
| Aug 20, 2026 | Parsa Kiai Director | Open-market purchase | +41,975 | $11.60 | $487,065 |
| Aug 20, 2026 | Parsa Kiai Director | Open-market purchase | +1,175 | $11.60 | $13,634 |
| Aug 19, 2026 | Parsa Kiai Director | Open-market purchase | +28,538 | $11.66 | $332,685 |
| Aug 19, 2026 | Parsa Kiai Director | Open-market purchase | +799 | $11.66 | $9,314 |
| May 26, 2026 | Jeffrey Matthew Rose Director | Grant or award | +11,680 | — | — |
| May 26, 2026 | Parsa Kiai Director | Grant or award | +11,680 | — | — |
| May 26, 2026 | Andrea B. Thomas Director | Grant or award | +11,680 | — | — |
| May 26, 2026 | Scott Schlackman Director | Grant or award | +11,680 | — | — |
| May 26, 2026 | Elizabeth A. Geary Director | Grant or award | +11,680 | — | — |
| May 26, 2026 | Jeffrey Matthew Rose Director | Grant or award | +6,739 | — | — |
| May 26, 2026 | Parsa Kiai Director | Grant or award | +7,637 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.